Netarsudil Ophthalmic Solution 0.02%: First Global Approval.
- Published in:
- Drugs, 2018, v. 78, n. 3, p. 389, doi. 10.1007/s40265-018-0877-7
- By:
- Publication type:
- Article
Works matching IS 00126667 AND DT 2018 AND VI 78 AND IP 3
Results: 8
1
2
Eculizumab: A Review in Generalized Myasthenia Gravis.
- Published in:
- Drugs, 2018, v. 78, n. 3, p. 367, doi. 10.1007/s40265-018-0875-9
- By:
- Publication type:
- Article
3
Correction to: Daratumumab: A Review in Relapsed and/or Refractory Multiple Myeloma.
- Published in:
- Drugs, 2018, v. 78, n. 3, p. 397, doi. 10.1007/s40265-018-0873-y
- By:
- Publication type:
- Article
4
Belimumab: A Review in Systemic Lupus Erythematosus.
- Published in:
- Drugs, 2018, v. 78, n. 3, p. 355, doi. 10.1007/s40265-018-0872-z
- By:
- Publication type:
- Article
5
Overview of Current Drugs and Molecules in Development for Spinal Muscular Atrophy Therapy.
- Published in:
- Drugs, 2018, v. 78, n. 3, p. 293, doi. 10.1007/s40265-018-0868-8
- By:
- Publication type:
- Article
6
Prevention and Treatment of Chronic Postsurgical Pain: A Narrative Review.
- Published in:
- Drugs, 2018, v. 78, n. 3, p. 339, doi. 10.1007/s40265-018-0866-x
- By:
- Publication type:
- Article
7
Efficacy and Safety of Tiotropium in Children and Adolescents.
- Published in:
- Drugs, 2018, v. 78, n. 3, p. 327, doi. 10.1007/s40265-018-0862-1
- By:
- Publication type:
- Article
8
Pharmacotherapy for Refractory and Super-Refractory Status Epilepticus in Adults.
- Published in:
- Drugs, 2018, v. 78, n. 3, p. 307, doi. 10.1007/s40265-017-0859-1
- By:
- Publication type:
- Article